Zolmitriptan Spray, Metered
Product Images NDC 69238-2352

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 69238-2352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zolmitriptan Nasal Spray Grunenthal 1)

Chemical Structure (Zolmitriptan Nasal Spray Grunenthal 1)
Chemical structure of zolmitriptan, an active ingredient used in nasal spray formulations. The diagram illustrates the molecular arrangement of atoms and bonds characteristic of zolmitriptan's chemical makeup.*
FDA Label Image

5 mg Carton (Zolmitriptan Nasal Spray Grunenthal 10)

5 mg Carton (Zolmitriptan Nasal Spray Grunenthal 10)
Packaging label for Zolmitriptan Nasal Spray 5 mg metered nasal spray. The carton indicates intranasal use only and contains 6 single-use nasal spray devices. The product is labeled as prescription only and is manufactured by Amneal Pharmaceuticals NY LLC, with distribution from Bridgewater, NJ. The label also includes a barcode and contact information.*
FDA Label Image

Figure 1 (Zolmitriptan Nasal Spray Grunenthal 2)

Figure 1 (Zolmitriptan Nasal Spray Grunenthal 2)
A line graph showing the estimated probability of response (%) over time in hours from the initial dose for zolmitriptan nasal sprays at 2.5 mg and 5.0 mg strengths compared to placebo. The 5.0 mg nasal spray shows the highest response rate, followed by the 2.5 mg spray, with placebo showing the lowest response over a 4-hour period.*
FDA Label Image

Figure 2 (Zolmitriptan Nasal Spray Grunenthal 3)

Figure 2 (Zolmitriptan Nasal Spray Grunenthal 3)
A graph showing the estimated probability (%) of taking an escape medication over 24 hours from the initial dose of zolmitriptan nasal spray at strengths 2.5 mg and 5 mg, compared to placebo. The x-axis represents hours from the initial dose, and the y-axis shows the probability percentage. The 5 mg nasal spray has the highest probability curve, followed by the 2.5 mg nasal spray and placebo with the lowest curve.*
FDA Label Image

Figure 3 (Zolmitriptan Nasal Spray Grunenthal 4)

Figure 3 (Zolmitriptan Nasal Spray Grunenthal 4)
A line graph comparing the estimated probability of rescue medication use over 24 hours post-dose between Zolmitriptan 5 mg nasal spray and placebo. The x-axis represents time post-dose in hours, and the y-axis shows the estimated probability percentage. Two lines depict Zolmitriptan 5 mg (N=231) and placebo (N=253), illustrating differences in rescue medication use over time.*
FDA Label Image

Figure A (Zolmitriptan Nasal Spray Grunenthal 5)

Figure A (Zolmitriptan Nasal Spray Grunenthal 5)
An instructional diagram labeled 'Figure A' showing two hands demonstrating how to handle or use a device, likely a nasal spray, with an arrow indicating movement or action between the parts held in each hand.*
FDA Label Image

Figure B (Zolmitriptan Nasal Spray Grunenthal 6)

Figure B (Zolmitriptan Nasal Spray Grunenthal 6)
An instructional illustration labeled Figure B showing a woman demonstrating the use of a nasal spray by placing the spray nozzle into one nostril, indicating the proper method for administering a metered nasal spray.*
FDA Label Image

Figure C (Zolmitriptan Nasal Spray Grunenthal 7)

Figure C (Zolmitriptan Nasal Spray Grunenthal 7)
Illustration labeled Figure C showing a hand holding a small nasal spray device, demonstrating proper grip and orientation for administering a metered nasal spray.*
FDA Label Image

Figure D (Zolmitriptan Nasal Spray Grunenthal 8)

Figure D (Zolmitriptan Nasal Spray Grunenthal 8)
Illustration showing a person demonstrating the proper use of Zolmitriptan nasal spray by inserting the spray nozzle into the nostril while holding the nose.*
FDA Label Image

2.5 mg Carton (Zolmitriptan Nasal Spray Grunenthal 9)

2.5 mg Carton (Zolmitriptan Nasal Spray Grunenthal 9)
The image shows packaging for Zolmitriptan Nasal Spray 2.5 mg, metered spray dosage form for intranasal use. The box indicates it contains 6 single-use nasal spray devices. The labeler is Amneal Pharmaceuticals NY LLC, with manufacturing noted by Farmaceutici Formenti S.p.A. The packaging includes branding, dosage, usage instructions, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.